Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

被引：0
|
作者：
Sunil Taneja
Ajay Duseja
Arka De
Manu Mehta
Raja Ramachandran
Vivek Kumar
Harbir Singh Kohli
Krishan Lal Gupta
Radha Krishan Dhiman
Yogesh Chawla
机构：
[1] Postgraduate Institute of Medical Education and Research,Department of Hepatology
[2] Postgraduate Institute of Medical Education and Research,Department of Nephrology
来源：
Digestive Diseases and Sciences | 2018年 / 63卷
关键词：
Chronic hepatitis C; Sofosbuvir; Daclatasvir; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1334 / 1340
页数：6
相关论文
共 50 条
  • [1] Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease
    Taneja, Sunil
    Duseja, Ajay
    De, Arka
    Mehta, Manu
    Ramachandran, Raja
    Kumar, Vivek
    Kohli, Harbir Singh
    Gupta, Krishan Lal
    Dhiman, Radha Krishan
    Chawla, Yogesh
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (05) : 1334 - 1340
  • [2] Low dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end stage renal disease.
    Duseja, Ajay K.
    Taneja, Sunil
    Mehta, Manu
    De, Arka
    Dhiman, Radha K.
    Chawla, Yogesh K.
    HEPATOLOGY, 2017, 66 : 614A - 615A
  • [3] The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease
    Behera, Manas K.
    Majji, Prabir
    Behera, Sanatan
    Pani, Manoj
    Mohapatro, Arupam
    Patra, Umesh C.
    Jena, Susanta K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 14 (04)
  • [4] Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis
    Taneja, Sunil
    Duseja, Ajay
    Mehta, Manu
    De, Arka
    Verma, Nipun
    Premkumar, Madhumita
    Dhiman, Radha K.
    Singh, Virendra
    Singh, Mini P.
    Ratho, Radha K.
    Ramachandran, Raja
    Kumar, Vivek
    Kohli, Harbir S.
    LIVER INTERNATIONAL, 2021, 41 (04) : 705 - 709
  • [5] Sofosbuvir and Ribavirin is safe and effective therapy in chronic hepatitis C patients with end-stage renal disease on haemodialysis
    Nayak, Sumanlata
    Sharma, Manoj
    Mathur, Rajendra P.
    Varma, Prem Prakash
    Gupta, Ekta
    Choudhary, Ashok
    Jamwal, Kapil D.
    Maiwall, Rakhi
    Kumar, Guresh
    Bhardwaj, Ankit
    Sarin, Shiv K.
    HEPATOLOGY, 2016, 64 : 425A - 425A
  • [6] The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment
    Poustchi, Hossein
    Majd Jabbari, Sara
    Merat, Shahin
    Sharifi, Amir-Houshang
    Shayesteh, Ali Akbar
    Shayesteh, Elahe
    Minakari, Mohammad
    Fattahi, Mohammad Reza
    Moini, Maryam
    Roozbeh, Fatemeh
    Mansour-Ghanaei, Fariborz
    Afshar, Behrooz
    Mokhtare, Marjan
    Amiriani, Taghi
    Sofian, Masoomeh
    Somi, Mohammad-Hossein
    Agah, Shahram
    Maleki, Iradj
    Latifnia, Maryam
    Fattahi Abdizadeh, Mojtaba
    Hormati, Ahmad
    Khoshnia, Masoud
    Sohrabi, Masoudreza
    Malekzadeh, Zeinab
    Merat, Dorsa
    Malekzadeh, Reza
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1590 - 1594
  • [7] Sofosbuvir-Based Treatment Is Safe and Effective in Patients With Chronic Hepatitis C Infection and End-Stage Renal Disease
    Alkhouri, Naim
    Guirguis, John
    Anthony, Sumi
    Rivas, John
    Hanouneh, Ibrahim A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S864 - S864
  • [8] Pharmacokinetics of half and full dose of sofosbuvir in chronic hepatitis C patients with end-stage renal disease
    Singhal, Ruchi
    Tiwari, Pramil
    Duseja, Ajay
    Taneja, Sunil
    Ramachandran, Raja
    Patial, Ajay
    Attri, Savita
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 260 - 260
  • [9] Efficacy of Low Dose Sofosbuvir and Daclatasvir in Treatment of Chronic Hepatitis C in Patients with End Stage Renal Disease
    Ijaz, Ahmar
    Akram, Mateen
    Anwar, Shahid
    Khan, Azhar Ali
    Saboor, Qazi
    Ibad-ur-Rehman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2022, 16 (01): : 140 - 142
  • [10] Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
    Liu, Chen-Hua
    Chen, Chi-Yi
    Su, Wei-Wen
    Tseng, Kuo-Chih
    Lo, Ching-Chu
    Liu, Chun-Jen
    Chen, Jyh-Jou
    Peng, Cheng-Yuan
    Shih, Yu-Lueng
    Yang, Sheng-Shun
    Huang, Chia-Sheng
    Huang, Ke-Jhang
    Chang, Chi-Yang
    Tsai, Ming-Chang
    Kao, Wei-Yu
    Fang, Yo-Jen
    Chen, Po-Yueh
    Su, Pei-Yuan
    Tseng, Chih-Wei
    Huang, Jow-Jyh
    Lee, Pei-Lun
    Lai, Hsueh-Chou
    Hsieh, Tsai-Yuan
    Chang, Chung-Hsin
    Huang, Yi-Jie
    Lee, Fu-Jen
    Chang, Chun-Chao
    Kao, Jia-Horng
    GUT, 2022, 71 (01) : 176 - 184
12345